Literature DB >> 26770568

Leukoaraiosis rather than lacunes predict poor outcome and chest infection in acute ischemic stroke patients.

Yaqi Duan1, Fei Chen2, Lang Lin3, Wei Wei4, Yonghua Huang4.   

Abstract

In this study, we determine the effects of leukoaraiosis and lacunes on the clinical outcome and relative complications of acute ischemic stroke patients. From January 2007 to June 2008, 323 consecutive patients with acute brain infarction were prospectively studied. Leukoaraiosis was defined as moderate or severe white matter hyperintensities, and lacunes were counted as follows: none (0 lacune), few (1-2 lacunes), and many (≥3 lacunes). During a three-month period after the onset of stroke, patient outcomes and the incidence of complications were assessed. Backward stepwise logistic regression was used to identify the independent predictors of adverse outcome and complications after stroke. During the follow-up, 128 patients (39.63%) experienced adverse outcomes (i.e., death or disability), and 69 patients (21.36%) developed chest infections. Leukoaraiosis was an independent predictor of adverse outcome and chest infection (adverse outcome: odds ratio, 3.971, 95% confidence interval, 1.954-8.073; chest infection: odds ratio, 1.809, 95% confidence interval, 1.220-2.681), whereas no associations were observed between lacunes and adverse outcomes or complications after stroke. In conclusion, Leukoaraiosis but not lacunes was an independent predictor of adverse outcomes and chest infection in acute ischemic stroke patients. The difference between the effects of lacunes and leukoaraiosis may reflect the heterogeneity of these two primary features of small vessel diseases.

Entities:  

Keywords:  Leukoaraiosis; complications; lacunes; prognosis; stroke

Year:  2015        PMID: 26770568      PMCID: PMC4694468     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Does leukoaraiosis predict morbidity and mortality?

Authors:  D P Briley; S Haroon; S M Sergent; S Thomas
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

2.  Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.

Authors: 
Journal:  Stroke       Date:  1990-04       Impact factor: 7.914

Review 3.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

4.  Brain tissue volumes and small vessel disease in relation to the risk of mortality.

Authors:  M Arfan Ikram; Meike W Vernooij; Henri A Vrooman; Albert Hofman; Monique M B Breteler
Journal:  Neurobiol Aging       Date:  2007-09-04       Impact factor: 4.673

5.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

6.  Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study.

Authors:  Anna Maria Basile; Leonardo Pantoni; Giovanni Pracucci; Kjell Asplund; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; John O'Brien; Philip Scheltens; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Domenico Inzitari
Journal:  Cerebrovasc Dis       Date:  2006-02-14       Impact factor: 2.762

7.  Leukoaraiosis more than dementia is a predictor of stroke recurrence.

Authors:  H Hénon; P Vroylandt; I Durieu; F Pasquier; D Leys
Journal:  Stroke       Date:  2003-11-20       Impact factor: 7.914

Review 8.  Leukoaraiosis: an independent risk factor for stroke?

Authors:  Domenico Inzitari
Journal:  Stroke       Date:  2003-06-26       Impact factor: 7.914

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial.

Authors:  S Aslanyan; C J Weir; H-C Diener; M Kaste; K R Lees
Journal:  Eur J Neurol       Date:  2004-01       Impact factor: 6.089

View more
  4 in total

1.  Multiple chronic lacunes predicting early neurological deterioration and long-term functional outcomes according to TOAST classification in acute ischemic stroke.

Authors:  Hyuk-Je Lee; Taewon Kim; Jaseong Koo; Young-Do Kim; Seunghee Na; Yun Ho Choi; In-Uk Song; Sung-Woo Chung
Journal:  Neurol Sci       Date:  2022-10-18       Impact factor: 3.830

2.  Relationship of white matter lesion severity with early and late outcomes after mechanical thrombectomy for large vessel stroke.

Authors:  Zimbul Albo; Jose Marino; Muhammad Nagy; Dilip K Jayaraman; Muhammad U Azeem; Ajit S Puri; Nils Henninger
Journal:  J Neurointerv Surg       Date:  2020-05-15       Impact factor: 5.836

3.  Prediction of Functional Outcome in Ischemic Stroke Patients: An Observational Study on Egyptian Population.

Authors:  Mohamed Mahmoud Fouad; Sherien Mohamed Farag; Mohamed I Hegazy; Mohamed Abd Elalem Aziz
Journal:  Cureus       Date:  2017-06-26

4.  Predictive value of the sequential organ failure assessment (SOFA) score for prognosis in patients with severe acute ischemic stroke: a retrospective study.

Authors:  Wei Qin; Xiaoyu Zhang; Lei Yang; Yue Li; Shuna Yang; Xuanting Li; Wenli Hu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.